Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abducens nerve paralysis
abducens nerve paralysis, bilateral
acetazolamide
adverse drug reaction
alcohol
antibodies to voltage-gated calcium channels
anticonvulsants, untoward effects of
arrhythmia, cardiac
ataxia
ataxia, hereditary
ataxia, paroxysmal
ataxia, truncal
ataxic gait
benign essential tremor
blind spot, enlarged
calcium, serum
carbonic anhydrase inhibitor
CAT scan
cerebellar ataxia, children
cerebral cortical atrophy
cerebrospinal fluid, childhood
cerebrospinal fluid, elevated protein of
cerebrospinal fluid, pressure increased
channelopathy
children
chloride channel dysfunction
chromosomal abnormality
cisternogram, radionuclide
coma
coma, episodic
controversies in neurology
cranial nerve palsies
dementia
dichlorphenamide
dieting
differential diagnosis
dilantin
diplopia
dizziness
down-beat nystagmus
down-beat nystagmus, primary position of gaze
drop attacks
dural sinus thrombosis
dysarthria
dystonia
electroencephalogram
electroencephalogram, abnormalities of
electromyogram
emergencies, neurologic
emergencies, ocular
empty sella
empty sella syndrome
endovascular therapy
enzyme, induction
episodic disorders
episodic neurologic deficits
exercise
eye movement, disorders of
facial nerve palsy
familial
familial periodic ataxia
fatigue
fundus, abnormality of
gender
gene mutation
genetic neurologic disorders
genetic testing
grasp reflex
headache
headache, chronic
headache, hypnic
headache, treatment of
hydrocephalus
hydrocephalus, normal pressure
hydrocephalus, treatment of
hyperkalemic periodic paralysis
hyperphosphatasia
hypocalcemia
hypokalemia
hypokalemic periodic paralysis
iatrogenic neurologic disorders
imbalance
incoordination
intracranial hypertension, benign
intracranial hypertension, benign, differential diagnosis
intracranial hypertension, benign, pathogenesis of
intracranial hypertension, benign, without papilledema
intracranial pressure, increased
intraocular pressure, increase
juvenile myoclonus epilepsy
kaliuresis
lumbar puncture
menses
metabolic acidosis
mexiletine
migraine
migraine, aura of
migraine, aura of, status
migraine, intractable
migraine, treatment of
molecular genetics
MRI
MRI, abnormal
muscle diseases, characteristics of
muscle weakness
muscle weakness, causes of
muscle weakness, sudden onset of
myokymia
myotonia
myotonia congenita
myotonia, treatment of
nausea and vomiting
neurologic disease, diagnoses of
neuromyotonia
nystagmus
nystagmus, hereditary
nystagmus, periodic
nystagmus, vertical
obesity
ophthalmoplegia
optic nerve sheath fenestration
optic nerve, decompression of
osteomalacia
papilledema
paramyotonia congenita
paresthesias
paroxysmal neurologic deficits
perimetry
periodic paralysis
phenobarbital
potassium channel dysfunction
precipitating factors
pregnancy, neurologic complications in
primary episodic ataxia
prognosis
psychological testing, neurologic problems
renal stones
retinal hemorrhages
review article
rickets
seizure
short stature
shunt procedure, lumboperitoneal
shunt procedure, ventriculo-peritoneal
sleep
sleep apnea
sleep apnea, central
slurred speech
sodium channel dysfunction
stent, intracranial
stent, venous sinus
stress, emotional
sudden death
thiazide diuretic
tonic foot response
transverse sinus stenosis
treatment of neurologic disorder
tremor
tremor, treatment of
trimethoprim-sulfamethoxazole
vertigo
vertigo, episodic
vertigo, migraine causing
vertigo, treatment of
vision, blurred
visual acuity, decreased
visual field defect
visual field testing
visual fields
visual loss
visual obscurations, transient
vitamin D
weight loss
weight management
Showing articles 600 to 650 of 866 << Previous Next >>

Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000

Efficacy of Rivastigmine in Dementia with Lewy Bodies: a Randomised, Double-blind, Placebo-controlled International Study
Lancet, 356:2031-2036,2024, McKeith,I.,et al, 2000

Selegiiline and Mortality in Subjects with Parkinson's Disease
Neurol 55:1785-1789,1770, Donnan,P.T.,et al, 2000

Donepezil Therapy in Clinical Practice, A Randomized Crossover Study
Arch Neurol 57:94-99, Greenberg,S.M.,et al, 2000

Tolcapone and Hepatotoxic Effects
Arch Neurol 57:263-267, Olanow,C.W.&Tasmar Advisory Panel, 2000

Cholesterol and Strokes
BMJ 320:459-460, Oliver,M.F., 2000

HMG-CoA Reductase Inhibitors (Statins)
Neurol 54:790-795, Hess,D.C.,et al, 2000

An 80-Year-Old Man With Memory Loss
JAMA 283:1046-1053, Larson,E.B., 2000

Depression in Parkinson's Disease
BMJ 320:1287-1288, Allain,H.,et al, 2000

Pyridostigmine-Induced Microcephaly
Neurol 54:1873-1874, Niesen,C.E.&Shah,N.S., 2000

The Catechol-O-Methyltransferase (COMT) Inhibitor Entacapone Enhances the Pharmacokinetic and Clinical Response to Sinemet CR in Parkinson's Disease
JNNP 68:589-594, Piccinni,P.,et al, 2000

Treating Nondementia Illnesses in Patients With Dementia
JAMA 283:3230-3235, Brauner,D.J. et al, 2000

Prevention of Radiographic-Contrast-Agent-Induced Reductions In Renal Function by Acetylcysteine
NEJM 343:180-184,210, Tepel,J. et al, 2000

Pravastatin Therapy and The Risk of Stroke
NEJM 343:317-326, White,H.D. et al, 2000

Serotonin Sydrome
Medicine 79:201-209, Mason,P.J. et al, 2000

Incidence and Prevalence of Neurological Disorders Associated with HIV Since the Introduction of Highly Active Antiretroviral Therapy (HAART)
JNNP 69:376-380, Maschke,M. et al, 2000

Relation Between Cholinesterase Inhibitor and Pisa Syndrome
Lancet 355:2222, Kwak,Y.T. et al, 2000

Antioxidant Therapy in Neurologic Disease
Arch Neurol 57:1265-1270, Delanty,N. & Dichter,M.A., 2000

Vitamin E and Beta Carotene Supplementation in High Risk for Stroke
Arch Neurol 57:1503-1509, Leppala,J.M.,et al, 2000

Statins and the Risk of Dementia
Lancet 356:1627-1631, Jick,H.,et al, 2000

AIDS-Related Focal Brain Lesions in the Era of Highly Active Antiretroviral Therapy
Neurol 55:1194-1200, Ammassari,A.,et al, 2000

Intake of Flavonoids, Carotenoids,Vitamins C and E, and Risk of Stroke in Male Smokers
Stroke 31:2301-2306, Hirvonen,T.,et al, 2000

HAART Improves Prognosis in HIV-Associated Progressive Multifocal Leukoencephalopathy
Neurol 52:623-625,440, Clifford,D.B.,et al, 1999

N-Acetylcysteine Therapy for Unverricht-Lundborg Disease
Neurol 52:426-427, Selwa,L.M., 1999

Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease:International Randomised Controlled
BMJ 318:633-640, 615, Rosler,M.,et al, 1999

Prevention of a First Stroke,A Review of Guidelines and a Multidisciplinary Consensus Statement from the National Stroke Association
JAMA 281:1112-1120,1146, Gorelick,P.B.,et al, 1999

Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
Neurol 52:1138-1145,1115, Neumann,P,J.,et al, 1999

Relation of Consumption of Vitamin E, Vitamin C, and Carotenoids to Risk for Stroke among Men in the United States
Ann Int Med 130:963-970, Ascherio,A.,et al, 1999

Randomized Trial of Sildenafil for the Treatment of Erectile Dysfunction in Spinal Cord Injury
Ann Neurol 46:15-21, Giuliano,F.,et al, 1999

Effect of Aldose Reductase Inhibition on Nerve Conduction and Morphomedtry in Diabetic Neuropathy
Neurol 53:580-591, Greene,D.A.,et al, 1999

Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke
Stroke 30:1969-1973, Vaughan,C.J.&Delanty,N., 1999

Clinical Benefits of Donepezil:Results from a Long-Term Phase III Extension Trial
Neurol 52:A174, Doody,R.S.,et al, 1999

Neostigmine for the Treatment of Acute Colonic Pseudo-Obstruction
NEJM 341:137-141, Ponec,R.J.,et al, 1999

Is Cholesterol a Risk Factor for Stroke? No
Arch Neurol 56:1521-1524, Landau,W.M., 1999

Is Cholesterol a Risk Factor for Stroke? Yes
Arch Neurol 56:1518-1520,1524, Demchuk,A.M.,et al, 1999

Treatment of Alzheimer's Disease
NEJM 341:1670-1679, Mayeux,R.&Sano,M, 1999

Effect of Vitamin C on Frequency of Reflex Sympathetic Dystrophty in Wrist Fractures:A Randomised Trial
Lancet 354:2025-2028, Zollinger,P.E.,et al, 1999

Clinicopath Conf,Sarcoidosis,with Involvement of Spinal Cord,Brain,Mediastinal Lymph Nodes and ? Lung,Case 35-1998
NEJM 339:1534-1541, , 1998

A 24-Week, Double-Blind, Placebo-Controlled Trial of Donepezil in Pts with Alzheimer's Disease
Neurol 50:136-145, Rogers,S.,et al, 1998

Dementia with Lewy Bodies:Response of Delirium-Like Features to Donepezil
Neurol 51:1512, Kaufer,D.I.,et al, 1998

Tasmar (tolcapone) Labeling Revisions of Package Insert
Roche Laboratories, , 1998

Mortality in People Taking Selegiline:Observational Study
BMJ 317:252-254, Thorogood,M.,et al, 1998

Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998

Investig of PDRG of UK into Excess Mortality Seen/Comb Levodopa & Selegiline Trmt in Pts with Early, Mild Parkinson's Dis
BMJ 316:1191-1196, Ben-Shlomo,Y.,et al, 1998

Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998

Random, Placebo-Contr Study of Tolcapone in Pts with Fluctuating Parkinson Dis Trtd With Levodopa-Carbidopa
Arch Neurol 55:1089-1095, Adler,C.H.,et al, 1998

Catechol-O-Methyltransferase Inhibitors for Treatment of Parkinson's Disease
Lancet 351:1221-1222, Nutt,J.G., 1998

Serotonin Syndrome Induced by Transitioning from Phenelzine to Venlafaxine:four Patient Reports
Neurol 51:274-276, Diamond,S.,et al, 1998

Progressive Multifocal Leukoencephalopathy, HIV, and Highly Active Antiretroviral Therapy
NEJM 339:848-849, Cinque,P.,et al, 1998

Effect of Selegiline on Mortality in Patients with Parkinson's Disease
Neurol 51:825-830, Olanow,C.W.,et al, 1998



Showing articles 600 to 650 of 866 << Previous Next >>